Home LiteratureArticle Details
PMID: 7693276 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock.

British journal of pharmacology ·Vol. 110 ·No. 1 ·1993-09-00 ·Pages 177-82

Thiemermann C, Wu CC, Szabó C, Perretti M, Vane JR

Abstract

1. This study investigates the role of tumour necrosis factor (TNF) in the induction of nitric oxide synthase (NOS) by bacterial endotoxin (lipopolysaccharide; LPS) in a rat model of endotoxin shock. 2. In anaesthetized rats, pretreatment with a monoclonal antibody for TNF (TNFab; 20 mg kg-1, s.c., at 16 h prior to LPS) ameliorated the fall in mean arterial blood pressure (MAP) in response to LPS (2 mg kg-1, i.v.). For instance, endotoxaemia for 180 min resulted in a fall in MAP from 114 +/- 6 (control) to 84 +/- 5 mmHg (P < 0.01; n = 7). In contrast, animals pretreated with TNFab prior to LPS injection maintained significantly higher MAP when compared to LPS-control (MAP at 180 min; 118 +/- 3 mmHg; P < 0.01, n = 5). 3. Three hours of endotoxaemia was also associated with a significant reduction of the contractile effects of noradrenaline (NA) (10(-8)-10(-6) M) on the thoracic aorta ex vivo. This hyporeactivity to NA was partially restored by in vitro treatment of the vessels with NG-nitro-L-arginine methyl ester (L-NAME, 20 min, 3 x 10(-4) M). Pretreatment of rats with TNFab (20 mg kg-1; at 16 h prior to LPS) significantly (P < 0.05) attenuated the LPS-induced hyporeactivity of rat aortic rings ex vivo. L-NAME did not enhance the contractions of aortic rings obtained from TNFab pretreated LPS-rats. 4. At 180 min after LPS there was a significant elevation of the induced NOS activity in the lung (5.14 +/- 0.57 pmol citrulline mg-1 min-1, n = 8). TNFab pretreatment significantly attenuated this induction of NOS in response to LPS by 37 +/- 6% (n = 5; P<0.05).5. We conclude that the formation of endogenous TNF contributes to the induction of the calcium in dependent isoform of NOS in response to LPS in vivo. Thus, the beneficial effects of agents which inhibit either the release or the action of TNF in circulatory shock may be, in part, due to inhibition of NOS induction.

MeSH Terms
Amino Acid Oxidoreductases/biosynthesis Anesthesia Animals Antibodies, Monoclonal/pharmacology Aorta, Thoracic/drug effects Enzyme Induction/drug effects Hemodynamics/drug effects In Vitro Techniques Lipopolysaccharides Male Nitric Oxide/metabolism Nitric Oxide Synthase Norepinephrine/pharmacology Rats Rats, Wistar Shock, Septic/enzymology,physiopathology Tumor Necrosis Factor-alpha/immunology,pharmacology
Chemicals
Antibodies, Monoclonal Lipopolysaccharides Tumor Necrosis Factor-alpha Nitric Oxide Nitric Oxide Synthase Amino Acid Oxidoreductases Norepinephrine
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Thiemermann C
William Harvey Research Institute, St. Bartholomew's Hospital Medical College, London.
Wu C C
Szabó C
Perretti M
Vane J R
References (51)
51 references, click to expand
  1. RP 55778, a PAF receptor antagonist, prevents and reverses LPS-induced hemoconcentration and TNF release.
    J Lipid Mediat. 1989 Nov-Dec;1(6):349-60 PMID: 2519903
  2. Nitric oxide: physiology, pathophysiology, and pharmacology.
    Pharmacol Rev. 1991 Jun;43(2):109-42 PMID: 1852778
  3. Monoclonal antibody to tumor necrosis factor alpha attenuates cardiopulmonary dysfunction in porcine gram-negative sepsis.
    Arch Surg. 1992 Feb;127(2):138-44; discussion 144-5 PMID: 1540090
  4. Characterization of nitric oxide synthases in non-adrenergic non-cholinergic nerve containing tissue from the rat anococcygeus muscle.
    Br J Pharmacol. 1991 Oct;104(2):289-91 PMID: 1724623
  5. Endogenous glucocorticoids regulate an inducible cyclooxygenase enzyme.
    Proc Natl Acad Sci U S A. 1992 May 1;89(9):3917-21 PMID: 1570314
  6. Tumor necrosis factor-alpha induces vascular hyporesponsiveness in Sprague-Dawley rats.
    Life Sci. 1992;50(19):1437-44 PMID: 1573976
  7. Molecular regulation of tumor necrosis factor-alpha and lymphotoxin production in T cells. Inhibition by prostaglandin E2.
    J Biol Chem. 1992 May 5;267(13):9443-9 PMID: 1533632
  8. In vivo and in vitro effects of endotoxin on vascular responsiveness to norepinephrine and signal transduction in the rat.
    Circ Shock. 1992 Feb;36(2):127-33 PMID: 1316243
  9. Overproduction of nitric oxide in cytokine-mediated and septic shock.
    J Natl Cancer Inst. 1992 Jun 3;84(11):827-31 PMID: 1375655
  10. Time course of various inflammatory mediators during recurrent endotoxemia.
    Biochem Pharmacol. 1992 May 28;43(10):2103-9 PMID: 1599496
  11. Nitric oxide mediates tumor necrosis factor-alpha cytotoxicity in endothelial cells.
    Biochem Biophys Res Commun. 1992 Jul 15;186(1):475-82 PMID: 1378728
  12. Reversal of hyperdynamic response to continuous endotoxin administration by inhibition of NO synthesis.
    J Appl Physiol (1985). 1992 Jul;73(1):324-8 PMID: 1506387
  13. Protective and pathological roles of nitric oxide in endotoxin shock.
    Cardiovasc Res. 1992 Jan;26(1):48-57 PMID: 1516112
  14. Nitric oxide as a secretory product of mammalian cells.
    FASEB J. 1992 Sep;6(12):3051-64 PMID: 1381691
  15. Characterization of cell selectivity of two novel inhibitors of nitric oxide synthesis.
    Eur J Pharmacol. 1992 May 27;216(1):131-4 PMID: 1382020
  16. The cardiodepressant and vasodepressant effects of tumour necrosis factor in rat isolated atrial and aortic tissues.
    Br J Pharmacol. 1992 Aug;106(4):942-7 PMID: 1382789
  17. Interferon-gamma and tumor necrosis factor synergize to induce nitric oxide production and inhibit mitochondrial respiration in vascular smooth muscle cells.
    Circ Res. 1992 Nov;71(5):1268-76 PMID: 1394884
  18. Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta.
    Br J Pharmacol. 1992 Sep;107(1):196-201 PMID: 1358382
  19. Synergistic stimulation of nitric oxide hemoglobin production in rats by recombinant interleukin 1 and tumor necrosis factor.
    Biochem Biophys Res Commun. 1992 Nov 30;189(1):392-7 PMID: 1333193
  20. Modulation of the induction of nitric oxide synthase by eicosanoids in the murine macrophage cell line J774.
    Br J Pharmacol. 1992 Nov;107(3):640-1 PMID: 1282071
  21. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide.
    Proc Natl Acad Sci U S A. 1993 Jan 1;90(1):267-71 PMID: 7678341
  22. Modulation of IL-1-induced neutrophil migration by dexamethasone and lipocortin 1.
    J Immunol. 1993 Feb 1;150(3):992-9 PMID: 8423349
  23. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock.
    Br J Pharmacol. 1993 Mar;108(3):786-92 PMID: 7682137
  24. Nifedipine inhibits the induction of nitric oxide synthase by bacterial lipopolysaccharide.
    J Pharmacol Exp Ther. 1993 May;265(2):674-80 PMID: 7684445
  25. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
    Anal Biochem. 1976 May 7;72:248-54 PMID: 942051
  26. Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.
    J Immunol. 1985 Dec;135(6):3972-7 PMID: 2999236
  27. Shock and tissue injury induced by recombinant human cachectin.
    Science. 1986 Oct 24;234(4775):470-4 PMID: 3764421
  28. Protective effect of WEB 2086, a novel antagonist of platelet activating factor, in endotoxin shock.
    Eur J Pharmacol. 1987 Mar 17;135(2):117-22 PMID: 3582490
  29. Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone.
    Clin Immunol Immunopathol. 1987 Dec;45(3):348-55 PMID: 3315338
  30. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.
    Nature. 1987 Dec 17-23;330(6149):662-4 PMID: 3317066
  31. Detection of circulating tumor necrosis factor after endotoxin administration.
    N Engl J Med. 1988 Jun 9;318(23):1481-6 PMID: 2835680
  32. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.
    J Clin Invest. 1988 Jun;81(6):1925-37 PMID: 3384955
  33. Release of tumor necrosis factor-alpha from macrophages. Enhancement and suppression are dose-dependently regulated by prostaglandin E2 and cyclic nucleotides.
    J Immunol. 1988 Oct 1;141(7):2388-93 PMID: 2844899
  34. Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages.
    Eur J Immunol. 1988 Oct;18(10):1587-92 PMID: 3142779
  35. Formation and release of nitric oxide from human neutrophils and HL-60 cells induced by a chemotactic peptide, platelet activating factor and leukotriene B4.
    FEBS Lett. 1989 Feb 27;244(2):357-60 PMID: 2537760
  36. Differential regulation of lipopolysaccharide-induced interleukin 1 and tumor necrosis factor synthesis: effects of endogenous and exogenous glucocorticoids and the role of the pituitary-adrenal axis.
    Eur J Immunol. 1989 Feb;19(2):301-5 PMID: 2784766
  37. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells.
    J Exp Med. 1989 May 1;169(5):1543-55 PMID: 2497225
  38. Effect of gram-negative endotoxin on levels of serum corticosterone, TNF alpha, circulating blood cells, and the survival of rats.
    Circ Shock. 1990 Mar;30(3):265-78 PMID: 2178800
  39. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha).
    Circ Shock. 1990 Mar;30(3):279-92 PMID: 2178801
  40. Endothelial cell production of nitrogen oxides in response to interferon gamma in combination with tumor necrosis factor, interleukin-1, or endotoxin.
    J Natl Cancer Inst. 1990 May 2;82(9):772-6 PMID: 2109093
  41. L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.
    Br J Pharmacol. 1990 Feb;99(2):408-12 PMID: 2328404
  42. NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension: implications for the involvement of nitric oxide.
    Proc Natl Acad Sci U S A. 1990 May;87(9):3629-32 PMID: 2333306
  43. Pentoxifylline increases survival in murine endotoxin shock and decreases formation of tumor necrosis factor.
    Circ Shock. 1990 Jun;31(2):171-81 PMID: 2344657
  44. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock.
    J Infect Dis. 1990 Aug;162(2):421-7 PMID: 2373872
  45. Platelet activating factor (PAF) and tumor necrosis factor-alpha (TNF alpha) interactions in endotoxemic shock: studies with BN 50739, a novel PAF antagonist.
    J Pharmacol Exp Ther. 1990 Oct;255(1):256-63 PMID: 2213560
  46. Loss of vascular responsiveness induced by endotoxin involves L-arginine pathway.
    Am J Physiol. 1990 Oct;259(4 Pt 2):H1038-43 PMID: 2221111
  47. Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharides in the rat in vivo.
    Eur J Pharmacol. 1990 Jul 17;182(3):591-5 PMID: 2226626
  48. Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat.
    Biochem Biophys Res Commun. 1990 Nov 15;172(3):1042-8 PMID: 1700903
  49. Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: an insight into endotoxin shock.
    Biochem Biophys Res Commun. 1990 Dec 14;173(2):541-7 PMID: 1701990
  50. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells.
    Proc Natl Acad Sci U S A. 1990 Dec;87(24):10043-7 PMID: 1702214
  51. Cytokines and their interactions with other inflammatory mediators in the pathogenesis of sepsis and septic shock.
    Eur J Clin Invest. 1991 Dec;21(6):559-73 PMID: 1778217
Article Info
Journal
British journal of pharmacology
Abbr.
Br J Pharmacol
ISSN
0007-1188
Published
1993-09-00
Pages
177-82
Language
English
Region
England
NLM ID
7502536
PMCID
PMC2176026
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]